Guest guest Posted March 27, 2008 Report Share Posted March 27, 2008 .... being investigated by FDA for possible increased risk of mood changes and suicidal behavior. Singulair is made by Merck, whose previous best-seller was Vioxx. FDA Probing Possible Link Between Asthma Drug and Suicide Risk 03.26.08, 8:00 PM ET THURSDAY, March 27 (HealthDay News) -- The U.S. Food and Drug Administration said Thursday it was investigating the possibility of an increased risk of mood changes and suicidal behavior among those who take the highly popular asthma drug Singulair. Singulair is the number one-selling drug among people aged 17 and younger. Last year, it posted sales of $4.3 billion, making it Merck & Co.'s top-selling product, according to the Associated Press. In issuing its statement, the FDA stressed that asthma patients should not stop taking Singulair without talking to their doctor first. Both Merck and the FDA noted that the two have been working together over the past year to determine the scope of the problem and to make appropriate labeling changes to reflect the potential risk of mood changes and suicidal behavior among Singulair users. " Suicide has been reported to us only in post-marketing experience in anecdotal reports that come to the company, " Philip, head of Merck's Singulair development program, told Bloomberg News. The company declined to say how many suicides have been reported, saying only that it is a " very small number " relative to the amount of people taking the drug. The company also released a statement Thursday that detailed the ongoing review. " Singulair has been marketed in the U.S. for 10 years and millions of patients have been prescribed Singulair in the U.S. and around the world. Merck voluntarily updated the worldwide product label for Singulair in October 2007 to include 'suicidal thinking and behavior' and included similar changes to the patient product information, " the company said in its statement. " These actions were based on a very limited number of post-marketing adverse event reports that Merck has received. Since that time, Merck has worked with the U.S. Food and Drug Administration to provide further clarity in the product label as well as to further communicate this information to physicians. " Over the past year, Merck has updated prescribing information for the drug to include information on several adverse events including tremor, depression, suicidality (suicidal thinking and behavior) and anxiousness, according to the FDA. And Merck plans to convey recent labeling changes in face-to-face meetings with prescribers and also in patient leaflets. http://www.forbes.com/forbeslife/health/feeds/hscout/2008/03/27/hscout613968.h tml ************** Create a Home Theater Like the Pros. Watch the video on AOL Home. (http://home.aol.com/diy/home-improvement-eric-stromer?video=15 & amp; ncid=aolhom00030000000001) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.